Treating Chronic Pain and Depression in HIV+ Patients in Primary Care Settings

Not Applicable

Completed

Brief Summary: The purpose of this study is to determine whether participation in the study intervention, which involves collaboration between the study interventionist and the participant's primary care physician, will reduce symptoms of pain and depression in HIV+ patients.

Recruitment & Eligibility

Inclusion Criteria

Chronic Pain (pain duration for at least six months with a mean score of 5 or higher on the BPI Pain Interference Scale)
Pain severity of 40 or higher on a Visual Analog Scale (0-100) indicating "worst pain in the last week"
At least one trial of PCP-recommended medication (i.e. acetominophen, NSAIDS, skeletal muscle relaxants) judged through interviews with patients and PCPs
QIDS score of ≥ 9 (depression severity)
Stable dose of an antidepressant, if using, for the previous 2 months
Age 18 or older
HIV+

Exclusion Criteria

Lifetime DSM-IV diagnosis of bipolar disorder, schizophrenia, or other chronic psychotic condition
Current DSM-IV diagnosis of substance dependence for alcohol, sedative/ hypnotic drugs, stimulants, or cocaine
Suicidal ideation or behavior requiring immediate attention
In psychotherapy or in a multidisciplinary pain management program
Expected surgery in the next 6 months
Pain thought to be due to cancer, infection, or inflammatory arthritis
Pregnancy

Arm && Interventions

Group	Intervention	Description
HIVPASS Intervention	HIVPASS	Participants in the HIVPASS intervention arm will receive 7 individual sessions with the study interventionist, the first of which is a collaborative meeting with the PCP. Sessions will focus on pain interference and depression management.
Health Education	Health Education	Participants in the Health Education arm will receive 7 individual sessions, each of which will focus on a different health education topic.

Primary Outcome Measures

Name	Time	Method
Brief Pain Inventory Interference Scale at 3 Months	3 months	Title: Brief Pain Inventory Interference Scale. Abbreviation: BPI-I. Measures: self-report of interference due to pain. Scale range: 0-10. Higher scores represent a worse outcome.

Secondary Outcome Measures

Name	Time	Method
Brief Pain Inventory Interference Scale at 12 Months	12 months	Title: Brief Pain Inventory Interference Scale. Abbreviation: BPI-I. Measures: self-report of interference due to pain. Scale range: 0-10. Higher scores represent a worse outcome.
Quick Inventory of Depression Symptoms at 12 Months	12 months	Quick Inventory of Depressive Symptoms. Abbreviation: QIDS. Measures: clinician-based assessment of depression symptom severity. Scale range: 0-27. Higher scores represent a worse outcome.
Quick Inventory of Depression Symptoms at 3 Months	3 months	Quick Inventory of Depressive Symptoms. Abbreviation: QIDS. Measures: clinician-based assessment of depression symptom severity. Scale range: 0-27. Higher scores represent a worse outcome.